Sex differences in fluorouracil-induced stomatitis

Journal of Clinical Oncology

Volumn 18, Issue 2, 2000, Pages 412-420

  Sloan, Jeff A ^a   Loprinzi, Charles L ^a   Novotny, Paul J ^a   Okuno, Scott ^a   Nair, Suresh ^a   Barton, Debra L ^a  

^a IL

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORBIDITY; PRIORITY JOURNAL; SEX DIFFERENCE; STOMATITIS;

EID: 0033955224     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.2.412     Document Type: Article

References (21)

1. Loprinzi CL, Cianflone SG, Dose AM, et al: A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer 65:1879-1882, 1990
2. Mahood DJ, Dose AM, Loprinzi CL, et al: Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 9:449-452, 1991
3. Rocke LK, Loprinzi CL, Lee JK, et al: A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer 72:2234-2238, 1993
4. Fidler P, Loprinzi CL, O'Fallon JR, et al: Prospective evaluation of chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer 77:522-525, 1996
5. Loprinzi CL, Ghosh C, Camoriano J, et al: Phase III controlled evaluation of sucralfate for alleviating stomatitis in patients receiving 5-FU (fluorouracil-based chemotherapy). J Clin Oncol 15:1235-1238, 1997
6. Okuno S, Woodhouse CO, Loprinzi CL, et al: A phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving 5FU-based chemotherapy. Am J Clin Oncol (in press)
7. Stewart LA: Meta-analysis of randomized controlled trials: Methodology - The good, the bad and the ugly. Radiother Oncol 48:10, 1998 (letter)
8. Parmar MKB, Torri V, Stewart LA: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815-2834, 1998
9. Gelber RD, Cole BF, Goldhirsch A, et al: Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: Meta-analysis of quality-adjusted survival. Lancet 347: 1066-1071, 1996
10. Barrett BJ, Carliste EJ: Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171-178, 1993
11. Meta-Analysis Group in Cancer: Toxicity of fluorouracil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors. J Clin Oncol 16:3537-3541, 1998
12. Stewart LA, Parmar MKB, Tierney JF: Meta-analyses and large randomized, controlled trials. N Engl J Med 338:61, 1998 (letter)
13. Meta-Analysis Group in Cancer: Efficacy of intravenous continuous infusion of Fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16:301-308, 1998
14. Advanced Colorectal Cancer Meta-Analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 10:896-903, 1992
15. Greimel ER, Padilla GV, Grant MM: Gender differences in outcomes among patients with cancer. Psychooncology 7:197-206, 1998
16. Dibble SL, Padilla GV, Dodd MJ, et al: Gender differences in the dimensions of quality of life. Oncol Nurs Forum 25:557-583, 1998
17. Kaul S, Srinivas NR, Mummaneni V, et al: Effects of gender, age, and race on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients. Semin Oncol 23:23-29, 1996
18. Palomares MR, Sayre JW, Shekar KC, et al: Gender influence on weight-loss pattern and survival of non small cell lung carcinoma patients. Cancer 78:2119-2126, 1996
19. Chessells JM, Richards SM, Bailey CC, et al: Gender and treatment outcome in childhood lymphoblastic leukemia: Report from the MRC UKALL trials. Br J Haematol 89:364-372, 1995
20. Rochon PA, Clark JP, Binns MA, et al: Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction. CMAJ 159:321-327, 1998
21. Chin MH, Goldman L: Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure. Med Care 36:1033-1046, 1998